Patient-Reported Outcomes of Benralizumab in Real-World Use in Severe Eosinophilic Asthma Patients in Taiwan (BEAT)
Clinical trial NCT05734339 · COMPLETED
Trial details
- NCT number
- NCT05734339
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-19
- Primary completion
- 2025-02-03
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.